Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -76.51% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -303.06% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 18.06% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 75.42% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 67.94% |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -26.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.72% |
| Dec 31, 2025 | -23.52% |
| Sep 30, 2025 | -37.75% |
| Jun 30, 2025 | 314.92% |
| Mar 31, 2025 | 45.73% |
| Dec 31, 2024 | 77.38% |
| Sep 30, 2024 | 36.94% |
| Jun 30, 2024 | 34.37% |
| Mar 31, 2024 | -11.26% |
| Dec 31, 2023 | -19.34% |
| Sep 30, 2023 | -21.96% |
| Jun 30, 2023 | -36.52% |
| Mar 31, 2023 | -43.16% |
| Dec 31, 2022 | -64.80% |
| Sep 30, 2022 | -38.52% |
| Jun 30, 2022 | -63.55% |
| Mar 31, 2022 | 21.42% |
| Dec 31, 2021 | 137.42% |
| Sep 30, 2021 | 224.87% |
| Jun 30, 2021 | 243.50% |